Galectin Therapeutics completes follow-on

Galectin Therapeutics Inc. (NASDAQ:GALT), Newton, Mass. Business: Cancer, Drug delivery Date completed: 3/22/12 Type: Follow-on Raised: $10.4 million Units: 1.2 million Price: $9 (unit) Shares after o...